Table 2. Distribution of Tim-3 Polymorphisms in All Groups.
| SNP | Genotype | HBV | HBsAg Seroclearance | HBV-associated HCC | Healthy Control |
| rs246871 | TT | 120(60.00%) | 117(58.50%) | 115(57.50%) | 111(55.50%) |
| (T>C) | CT | 69(34.50%) | 76(38.00%) | 58(29.00%) | 73(36.50%) |
| CC | 11(5.50%) | 7(3.50%) | 27(13.50%) | 16(8.00%) | |
| Allele | T | 309(77.25%) | 310(77.50%) | 288(72.00%) | 295(73.75%) |
| C | 91(22.75%) | 90(22.50%) | 112(28.00%) | 105(26.25%) | |
| rs25855 | GG | 68(34.00%) | 90(45.00%) | 90(45.00%) | 74(37.00%) |
| (G>A) | AG | 105(52.50%) | 83(41.50%) | 84(42.00%) | 102(51.00%) |
| AA | 27(13.50%) | 27(13.50%) | 26(13.00%) | 24(12.00%) | |
| Allele | G | 241(60.00%) | 263(66.00%) | 264(66.00%) | 250(63.00%) |
| A | 159(40.00%) | 137(34.00%) | 136(34.00%) | 150(38.00%) | |
| rs31223 | TT | 71(35.50%) | 64(32.00%) | 71(35.50%) | 80(40.00%) |
| (T>C) | CT | 98(49.00%) | 82(41.00%) | 95(47.50%) | 90(45.00%) |
| CC | 31(15.50%) | 54(27.00%) | 34(17.00%) | 30(15.00%) | |
| Allele | T | 240(60.00%) | 210(52.50%) | 237(59.25%) | 250(62.50%) |
| C | 160(40.00%) | 190(47.50%) | 163(40.75%) | 150(37.50%) |
Distribution of each SNP was shown in number and frequency.